Physician

Elizabeth Shanika Esparaz, MD

According to 2025 Medicare claims, Elizabeth Esparaz, MD (NPI: 1053654004) practices ophthalmology in the Akron, OH market, with the plurality of this provider's patient population coming from Portage, OH. This provider's primary affiliated billing organization is NORTHEAST OHIO EYE SURGEONS, INC. (NPI: 1932208733; TIN: 341447430) and primary practice location at 44240-4113.

Esparaz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 161 traditional Medicare patients, billed 9,443 HCPCS/CPT codes, and received $627,443 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 332 prescription claims across 138 beneficiaries totaling $18,000 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 11 records totaling $296. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,383 to $627,443. In contrast, Part D prescription costs have fallen sharply in recent years, from $33,109 to $18,000. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$314K$627K2017 Medicare payment: $4,383 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $76,522 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $193,867 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $315,872 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $453,603 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $497,906 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $479,348 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $627,443 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20174470$4,383
2018224968$76,522
20193011,982$193,867
20203632,320$315,872
20213422,429$453,603
20222742,663$497,906
20231633,630$479,348
20241619,443$627,443

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$44K$88K2015 Drug cost: $33,109 (USD; Tot_Drug_Cst)2016 Drug cost: $32,647 (USD; Tot_Drug_Cst)2017 Drug cost: $40,063 (USD; Tot_Drug_Cst)2018 Drug cost: $26,368 (USD; Tot_Drug_Cst)2019 Drug cost: $52,153 (USD; Tot_Drug_Cst)2020 Drug cost: $60,387 (USD; Tot_Drug_Cst)2021 Drug cost: $87,746 (USD; Tot_Drug_Cst)2022 Drug cost: $47,828 (USD; Tot_Drug_Cst)2023 Drug cost: $19,785 (USD; Tot_Drug_Cst)2024 Drug cost: $18,000 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015104451$33,109
2016151560$32,647
2017196945$40,063
2018177498$26,368
2019201640$52,153
2020249632$60,387
2021284829$87,746
2022217672$47,828
2023117300$19,785
2024138332$18,000

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg43395$658
67028Injection of drug into eye75373$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more118164$79
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4361$61
92134Imaging of retina120438$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate291,221$1,257
ErythromycinErythromycin Base1192,820$1,234
Ketorolac TromethamineKetorolac Tromethamine241,127$489
LatanoprostLatanoprost342,152$380
Timolol MaleateTimolol Maleate291,857$332

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$296Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Elizabeth Shanika Esparaz, MD?

Tedicare shows public-source Medicare data for Elizabeth Shanika Esparaz, MD (NPI 1053654004), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elizabeth Shanika Esparaz, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Elizabeth Shanika Esparaz, MD?

Elizabeth Shanika Esparaz, MD is linked to NORTHEAST OHIO EYE SURGEONS, INC. (billing NPI 1932208733) in the available physician profile data.

Does Elizabeth Shanika Esparaz, MD have Open Payments data?

Elizabeth Shanika Esparaz, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.